Form D · Pharmaceuticals
ESSENTIA PHARMA FLORIDA, LLC
Rosenberg, TX · CIK 0001760349
Offering snapshot reported Dec 6, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 6, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-327288
Source: Form D, filed Dec 6, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Doug Devries | Executive |
| Stacy Foster | Executive |
| Charles Hewitt | Executive |
| Paul Karpecki | Executive |
| Michael O'toole | Executive |
| Troy Smith | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
30444 Southwest Freeway
Rosenberg, TX, 77471
Rosenberg, TX, 77471